A Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics of PF-07081532

Status:
Not yet recruiting

Trial end date:
2023-10-25

Target enrollment:

Participant gender:

A Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics of PF-07081532, one 20 mg tablet administered orally.

Phase 1

Pfizer